Shuttle Pharmaceuticals Holdings Inc (SHPH)
0.882
-0.02
(-1.78%)
USD |
NASDAQ |
Nov 21, 16:00
0.9535
+0.07
(+8.11%)
After-Hours: 07:55
Shuttle Pharmaceuticals Holdings Enterprise Value: 3.326M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 3.326M |
| November 20, 2024 | 3.384M |
| November 19, 2024 | 3.359M |
| November 18, 2024 | 3.505M |
| November 15, 2024 | 3.747M |
| November 14, 2024 | 4.015M |
| November 13, 2024 | 4.161M |
| November 12, 2024 | 3.936M |
| November 11, 2024 | 4.003M |
| November 08, 2024 | 3.970M |
| November 07, 2024 | 4.003M |
| November 06, 2024 | 4.270M |
| November 05, 2024 | 4.605M |
| November 04, 2024 | 5.440M |
| November 01, 2024 | 5.674M |
| October 31, 2024 | 6.342M |
| October 30, 2024 | 5.396M |
| October 29, 2024 | 5.396M |
| October 28, 2024 | 4.012M |
| October 25, 2024 | 3.776M |
| October 24, 2024 | 3.879M |
| October 23, 2024 | 3.982M |
| October 22, 2024 | 4.277M |
| October 21, 2024 | 3.894M |
| October 18, 2024 | 3.599M |
| Date | Value |
|---|---|
| October 17, 2024 | 3.658M |
| October 16, 2024 | 3.599M |
| October 15, 2024 | 3.364M |
| October 14, 2024 | 3.694M |
| October 11, 2024 | 3.393M |
| October 10, 2024 | 3.364M |
| October 09, 2024 | 3.128M |
| October 08, 2024 | 3.305M |
| October 07, 2024 | 3.481M |
| October 04, 2024 | 3.526M |
| October 03, 2024 | 3.555M |
| October 02, 2024 | 3.599M |
| October 01, 2024 | 3.658M |
| September 30, 2024 | 4.012M |
| September 27, 2024 | 2.376M |
| September 26, 2024 | 2.465M |
| September 25, 2024 | 2.318M |
| September 24, 2024 | 2.494M |
| September 23, 2024 | 2.524M |
| September 20, 2024 | 2.789M |
| September 19, 2024 | 3.260M |
| September 18, 2024 | 2.184M |
| September 17, 2024 | 2.318M |
| September 16, 2024 | 2.229M |
| September 13, 2024 | 2.274M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
0.7714M
Minimum
Sep 27 2023
697.25M
Maximum
Sep 01 2022
18.31M
Average
4.547M
Median
Sep 05 2023
Enterprise Value Benchmarks
| Oragenics Inc | 2.273M |
| Lixte Biotechnology Holdings Inc | 5.281M |
| Soligenix Inc | 0.6511M |
| Tonix Pharmaceuticals Holding Corp | 17.92M |
| NovaBay Pharmaceuticals Inc | 2.798M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.784M |
| Total Expenses (Quarterly) | 3.052M |
| EPS Diluted (Quarterly) | -1.59 |
| Earnings Yield | -475.1% |